BioLASCO Taiwan Co., Ltd. (TPEX:6662)
33.90
+0.05 (0.15%)
Jun 5, 2025, 12:51 PM CST
BioLASCO Taiwan Revenue
BioLASCO Taiwan had revenue of 59.87M TWD in the quarter ending March 31, 2025, with 25.47% growth. This brings the company's revenue in the last twelve months to 304.65M, up 15.69% year-over-year. In the year 2024, BioLASCO Taiwan had annual revenue of 292.50M with 10.49% growth.
Revenue (ttm)
304.65M
Revenue Growth
+15.69%
P/S Ratio
2.85
Revenue / Employee
3.35M
Employees
91
Market Cap
868.25M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 292.50M | 27.78M | 10.49% |
Dec 31, 2023 | 264.72M | 28.81M | 12.21% |
Dec 31, 2022 | 235.91M | 8.33M | 3.66% |
Dec 31, 2021 | 227.58M | -71.30M | -23.86% |
Dec 31, 2020 | 298.88M | -47.81M | -13.79% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 20.87B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 87.67M |
Lumosa Therapeutics | 43.59M |
Center Laboratories | 1.63B |
Oneness Biotech | 117.33M |